Table 2 Distribution of sociodemographic factors and known or suspected risk factors or protective factors for colorectal cancer among 380 cases and 485 controls included in the analysis.
| Characteristic | Level | Cases | Controls | ||||
|---|---|---|---|---|---|---|---|
| n | % | n | % | ||||
| Age (years) | 30–49 | 17 | 4.5 | 30 | 6.2 | ||
| 50–59 | 55 | 14.5 | 87 | 18.0 | |||
| 60–69 | 153 | 40.3 | 182 | 37.5 | |||
| 70–79 | 103 | 27.1 | 133 | 27.4 | |||
| 80+ | 52 | 13.7 | 53 | 10.9 | |||
| Sex | Female | 170 | 44.7 | 214 | 44.1 | ||
| Male | 210 | 55.3 | 271 | 55.9 | |||
| Education | ⩽9 years | 272 | 71.6 | 311 | 64.1 | ||
| 10–11 years | 61 | 16.1 | 89 | 18.4 | |||
| ⩾12 years | 47 | 12.4 | 85 | 17.5 | |||
| Participation in general health screening examination | Ever | 276 | 73.4 | 414 | 85.5 | ||
| Family history | First degree relative* | 41 | 10.8 | 51 | 10.5 | ||
| Smoking | Never | 177 | 46.8 | 239 | 49.3 | ||
| Current | 61 | 16.1 | 73 | 15.0 | |||
| Former | 140 | 37.0 | 173 | 35.7 | |||
| Body mass index | <20.0 kg/m2 | 24 | 6.4 | 12 | 2.5 | ||
| 20.0–24.9 kg/m2 | 132 | 35.4 | 166 | 34.2 | |||
| 25.0–29.9 kg/m2 | 139 | 37.3 | 224 | 46.2 | |||
| ⩾30.0 kg/m2 | 78 | 20.9 | 83 | 17.1 | |||
| NSAID use | Ever regular† | 114 | 30.0 | 176 | 36.3 | ||
| HRT use | Ever regular‡ | 49 | 29.5 | 112 | 52.3 | ||
*History of colorectal cancer in first degree relative.
†Ever regular use of aspirin or NSAID (at least once a month for one year).
‡Ever use of hormonal replacement therapy (women only).
HRT, hormone replacement therapy; NSAID, non‐steroidal anti‐inflammatory drug.